Lieven Elvire Colette Baert
19Patents
3h-index
30Co-inventors
60Inventor score
Filing activity: May 20, 1998 → Sep 13, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7081255B2 | Antifungal compositions with improved bioavailability | Human Necessities | 19 | Expired |
| US6509038B2 | Antifungal compositions with improved bioavailability | Human Necessities | 8 | Expired |
| US8426434B2 | Crystalline form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile | Human Necessities | 4 | Active |
| US9682096B2 | Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections | Chemistry; Metallurgy | 3 | Active |
| US6365188B1 | Solid mixtures of cyclodextrins prepared via meltextrusion | Performing Operations; Transporting | 2 | Expired |
| US10765674B2 | Prevention of HIV-infection | Human Necessities | 1 | Active |
| US11389447B2 | Aqueous suspensions of TMC278 | Human Necessities | 1 | Active |
| US9987300B2 | Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections | Chemistry; Metallurgy | 1 | Active |
| US10953009B2 | Long term treatment of HIV-infection with TMC278 | Human Necessities | 1 | Active |
| US8754093B2 | Co-crystal of etravirine and nicotinamide | Chemistry; Metallurgy | 0 | Active |
| US8591948B2 | Antifungal compositions with improved bioavailability | Human Necessities | 0 | Active |
| USRE50189E1 | Long term treatment of HIV-infection with TMC278 | General | 0 | Active |
| US11395867B2 | Degradable removable implant for the sustained release of an active compound | Human Necessities | 0 | Active |
| US8557854B2 | Use of a sulfonamide compound for improving the pharmacokinetics of a drug | Human Necessities | 0 | Active |
| US8916558B2 | Powders for reconstitution | Human Necessities | 0 | Active |
| US10485816B2 | Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections | Chemistry; Metallurgy | 0 | Active |
| US8784858B2 | Degradable removable implant for the sustained release of an active compound | Human Necessities | 0 | Active |
| US9603803B2 | Process for preparing spray dried formulations of 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile | Human Necessities | 0 | Active |
| US10744235B2 | Degradable removable implant for the sustained release of an active compound | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.